1-10 of 10
Keywords: pseudokinase
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2024) 481 (17): 1125–1142.
Published: 27 August 2024
...Sarah E. Garnish; Christopher R. Horne; Yanxiang Meng; Samuel N. Young; Annette V. Jacobsen; Joanne M. Hildebrand; James M. Murphy Necroptosis is a lytic and pro-inflammatory form of programmed cell death executed by the terminal effector, the MLKL (mixed lineage kinase domain-like) pseudokinase...
Includes: Supplementary data
Articles
Biochem J (2023) 480 (2): 141–160.
Published: 23 January 2023
...Dominic P. Byrne; Safal Shrestha; Leonard A. Daly; Vanessa Marensi; Krithika Ramakrishnan; Claire E. Eyers; Natarajan Kannan; Patrick A. Eyers Pseudokinases, so named because they lack one or more conserved canonical amino acids that define their catalytically active relatives, have evolved...
Includes: Multimedia, Supplementary data
Articles
Biochem J (2020) 477 (17): 3387–3399.
Published: 17 September 2020
...Jinle Tang; Yingjie Wang; Huan Zhou; Yuxin Ye; Manisha Talukdar; Ziyang Fu; Zhihong Liu; Jihui Li; Dante Neculai; Jiali Gao; Hao Huang The pseudokinase (PK) RNase L is a functional ribonuclease and plays important roles in human innate immunity. The ribonuclease activity of RNase L can be regulated...
Includes: Supplementary data
Articles
Articles
Biochem J (2015) 465 (2): 195–211.
Published: 06 January 2015
... (the kinome) encodes approximately 50 ‘pseudokinases’, which were initially predicted to be incapable of dynamic cell signalling when compared with canonical enzymatically active kinases. This assumption was supported by bioinformatics, which showed that amino acid changes at one or more key loci, making up...
Articles
Biochem J (2014) 462 (1): 1–13.
Published: 24 July 2014
... diseases, including haemopoietic malignancies, immunodeficiency and inflammatory diseases. At the molecular level, recent studies have greatly advanced our knowledge of the structures and organization of the component FERM (4.1/ezrin/radixin/moesin)-SH2 (Src homology 2), pseudokinase and kinase domains...
Articles
Articles
Articles
Articles